Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 877 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

FDA approves Genentech BCC drug

Erivedge capsule, taken orally once-a-day, is the first FDA-approved medicine for people with advanced forms of the most common skin cancer. The approval is based on results from

Durect regains Posidur rights

Posidur is a post-operative pain relief depot that utilizes Durect’s patented Saber technology to deliver bupivacaine and is designed to provide up to three days of pain relief

Watson to establish new R&D Technology Center

The company plans to retrofit 19,000sqft of space for product development and analytical laboratories. The remaining 13,000sqft will accommodate future expansion. Watson Pharmaceuticals intends to initially invest approximately